Peripheral oxidative stress biomarkers in mild cognitive impairment and alzheimer's disease

Journal of Alzheimer's Disease

Volumn 26, Issue 1, 2011, Pages 59-68

  Torres, Larissa Lobo ^a   Quaglio, Nathalia Barbosa ^a   De Souza, Gisele Tavares ^a   Garcia, Raphael Tamborelli ^a   Dati, Lívia Mendonça Munhoz ^a   Moreira, Wallace Luiz ^a   De Melo Loureiro, Ana Paula ^a   De Souza Talarico, Juliana Nery ^a   Smid, Jerusa ^a   Porto, Cláudia Selito ^a   De Campos Bottino, Cássio MacHado ^a   Nitrini, Ricardo ^a   De Moraes Barros, Silvia Berlanga ^a   Camarini, Rosana ^a   Marcourakis, Tania ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aging; Alzheimer's disease; antioxidant enzymes; malonaldehyde; mild cognitive impairment; oxidative stress

Indexed keywords

BIOLOGICAL MARKER; CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LIPID; MALONALDEHYDE;

AGED; AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 80052844164     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110284     Document Type: Article

References (81)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment; clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
2. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stage Alzheimer's disease. Arch Neurology 58, 397-405. (Pubitemid 32217456)
3. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erk-injuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246. (Pubitemid 39222993)
4. Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11, 298-300.
5. Maccioni RB, Munoz JP, Barbeito L (2001) The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 32, 367-381. (Pubitemid 32918139)
6. Praticò D, Delanty N (2000 a) Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am J Med 109, 577-585.
7. Casado A, López-Fernandez ME (2003) Age-correlated changes of the erythrocyte catalase activity in the Spanish population. Gerontology 49, 251-254. (Pubitemid 36693860)
8. Junqueira VBC, Barros BM, Chan SS, Rodrigues L, Giavarotti L, Abud RL, Deucher GP (2004) Aging and oxida-tive stress. Mol Aspects Med 25, 5-16.
9. Kasapoglu M, Özben T (2001) Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Geront 36, 209-220. (Pubitemid 32164433)
10. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88, 10540-10543. (Pubitemid 21915871)
11. Sultana R, Butterfield A (2010) Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimer Dis 19, 341-353
12. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60, 759-767. (Pubitemid 32678256)
13. Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 7, 548-554. (Pubitemid 33127140)
14. Bermejo P, Martin-Aragón S, Benedi J, Susin C, Felici E, Gil P, Ribeira J, Villar AM (2008) Peripheral levels of glu-tathione and protein oxidation as markers in the development of Alzheimer's disease from mild cognitive impairment. Free Radic Res 42, 162-170. (Pubitemid 351298365)
15. Picklo MJ, Montine TJ, Amarnath V, Neely MD (2002) Carbonyl toxicology and Alzheimer's disease. Toxicol Appl Pharmacol 184, 187-197. (Pubitemid 35428851)
16. Smith MA, Sayre LM, Anderson VE, Harris PLR, Beal MF, Kowall N, Perry G (1998) Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2, 4- dinitrophenylhydrazine. J Histochem Cytochem 46, 731-735. (Pubitemid 28272207)
17. Teunissen CE, de Vente J, Steinbusch HWM, de Bruijn C (2002) Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol Aging 23, 485-508. (Pubitemid 34495461)
18. Markesbery WR, Lovell MA (2006) DNA oxidation in Alzheimer's disease. Antioxidants Redox Signal 8, 2039-2045. (Pubitemid 46489629)
19. Mecocci P, Polidori MC, Cherubini A, Ingegni T, Mattioli P, Catani M, Rinaldi P, Cecchetti R, Stahl W, Senin U, Beal MF (2002) Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 59, 794-798. (Pubitemid 34517762)
20. Migliore L, Fontana I, Colognato R, Coppede F, Siciliano G, Murri L (2005) Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases. Neurobiol Aging 26, 587-595. (Pubitemid 40228750)
21. Nunomura A, Honda K, Takeda A, Hirai K, Zhu X, Smith MA, Perry G (2006) Oxidative damage to RNA in neurodegenerative diseases. J Biomed Biotechnol 2006, 1-6.
22. Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW (2002) Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun 293, 1566-1570. (Pubitemid 34681057)
23. Delibas N, Ozcankaya R, Altuntas I (2002) Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval. Clin Biochem 32, 137-141. (Pubitemid 34442693)
24. Hülya H, Ercan F, Aslan D, Sahiner T (2007) Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey. Clin Biochem 40, 172-176. (Pubitemid 46108698)
25. Kawamoto EM, Munhoz CD, Glezer I, Bahia VS, Caramelli P, Nitrini R, Gorja ̃o R, Curi R, Scavone C, Marcourakis T (2005) Oxidative stress in platelets and erythrocytes in aging and Alzheimer's disease. Neurobiol Aging 26, 857-64. (Pubitemid 40249488)
26. Martin-Aragón S, Bermejo-Bescós P, Benedi J, Felici E, Gil P, Ribeira JM, Villar AM (2009) Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease. Neurochem Res 34, 373-378.
27. Montine TJ, Markesbery WR, Roberts LJ, Morrow JD (1998) Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann Neurol 4, 410-413. (Pubitemid 28421451)
28. Waddington E, Croft K, Clarnette RM, Artibs R (1999) Plasma F2-isoprostane levels are increased in Alzheimer's disease: evidence of increased oxidative stress in vivo. Alzheimer's Rep 2, 227-282.
29. Praticò D, Clark CM, Lee VMY, Trojanowski JQ, Rokach J, FitzGerald G (2000 b) Increased 8, 12-iso-iPF2α-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann Neurol 48, 809-812.
30. McGrath LT, McGleenon BM, Brennan S, McColl D, McIl-roy S, Passmore AP (2001) Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJMed 94, 485-490. (Pubitemid 32894467)
31. Ding Q, Markesbery WR, Chen Q, Li F, Keller JN (2005) Ribossome dysfunction is an early event in Alzheimer's disease. J Neurosci 25, 9171-9175. (Pubitemid 41500825)
32. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesberry WR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64, 1152-1156.
33. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C (2010) Changes of some oxidative stress mark-ers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 469, 6-10.
34. Baldeiras I, Santana I, Proença MT, Garrucho MH, Pascoal R, Rodrigues A, Duro D, Oliveira CR (2008) Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. J Alzheimer Dis 15, 117-128.
35. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimeŕs disease. Neurobiol Aging 24, 915-919. (Pubitemid 36962976)
36. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
37. Mattis S. Dementia rating scale. Professional Manual. Florida: Psychological Assessment Resources, Inc, 1988.
38. Porto CS, Fichman HC, Caramelli P, Bahia VS, Nitrini R (2003) Brazilian version ofthe Mattis Dementia Rating Scale: diagnosis of mild dementia in Alzheimer's disease. Arq Neu-ropsiquiatr 61, 339-345. (Pubitemid 36850890)
39. Wechsler D. Wechsler Memory Scale. Manual The Psychological Corporation Harcourt Brace Jovanovich, 1987.
40. Halliwell B, Gutteridge JMC (2007) Free Radical in Biology and Medicine, fourth ed. Oxford, New York.
41. van Hoorn EC, Sutmuller-Ooms M, de Vrij G, van Leeuwen PAM, van Norren K (2003) A fast and accurate method to measure both oxidative stress and vitality in a single organ slice. Anal Biochem 320, 82-87. (Pubitemid 36937070)
42. Sim AS, Salonikas C, Naidoo D, Wilcken DEL (2003) Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. J Chromatogr B 785, 337-344. (Pubitemid 36126174)
43. Flohé L, Günzler WA (1984) Assays of glutathione preoxi-dase. Meth Enzymol 105, 114-21.
44. Calberg I, Mannervik B (1975) Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250, 5475-5480.
45. Giutarini D, Dalle-Donne I, Colombo R, Milzani A, Rossi R (2003) Animproved HPLC measurement for GSH and GSSG in human blood. Free Radic Biol Med 35, 1365-1372. (Pubitemid 37452462)
46. Rossi R, Dalle-Donne I, Milzani A, Giustarini D (2006) Oxidized forms of glutathione in peripheral blood as biomarkers of oxidative stress. Clin Chem 52, 1406-1414. (Pubitemid 43956034)
47. Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases the first enzymatic step in mercapturic acid formation. J Biol Chem 22, 7130-7139.
48. Aebi H (1984) Catalase in vitro. Meth Enzymol 105, 121-126.
49. Goodman Y, Mattson MP (1994) Secreted forms of betaamy-loid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp Neurol 128, 1-12.
50. Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxida-tion and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23, 655-64. (Pubitemid 35217687)
51. Sultana R, Butterfield A (2009) Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J Bioenerg Biomembr 41, 441-446.
52. Keller JN, Mark RJ, Bruce AJ, Blanc E, Rothstein JD, Uchida K, Waeg G, Mattson MP (1997) 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synapto-somes. Neuroscience, 80, 685-696. (Pubitemid 27334614)
53. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP (1997) Amyloid beta-peptide impairs glucose transport in hippocam-pal and cortical neurons: Involvement of membrane lipid peroxidation. J Neuroscience, 17, 1046-1054. (Pubitemid 27043963)
54. Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, Emeriau JP, Rainfray M (2001) Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Aging 30, 235-241. (Pubitemid 32684904)
55. Casado A, López-Fernández E, Casado MC, de La Torre R (2008) Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 33, 450-458. (Pubitemid 351230446)
56. Greilberger J, Koidl C, Greilberger M, Lamprecht M, Schroecksnadel K, Leblhuber F, Fuchs D, Oerrl K (2008) Malondialdehyde, carbonyl proteins and albumi-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radic Res 42, 633-638.
57. Zafrilla P, Mulero J, Xandri JM, Santo E, Caravaca G, Morillas JM (2006) Oxidative stress in Alzheimer patients in different stages of the disease. Curr Med Chem 13, 1075-1083.
58. Perin R, Briançon S, Jeandel C, Artur Y, Minn A, Penin F, Siest G (1990) Blood activity of Cu/Zn superoxide dismu-tase and catalase in Alzheimer's disease: a case control study. Gerontology 36, 306-313.
59. Annerén G, Gardner A, Lundin T (1986) Increased glu-tathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer1s type. Acta Neurol Scand 73, 586-589. (Pubitemid 16057828)
60. Venarucci D, Venarucci V, Vallese A, Battila L, Casado A, de la Torre R, Lopez-Fernandez M (1991) Free radicals: important cause of pathologies refer to ageing. Panminerva Med 41, 335-339.
61. dela Torre R, Casado A, López-Fernández ME, Carrascosa D, Casado MC, Venarucci D, Venarucci V (1996) Human aging brain disorders: role of antioxidant enzymes. Neurochem Res 21, 885-888.
62. Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Phisiol Rev 59, 527-605. (Pubitemid 9236599)
63. Ceballos-Picot I, Merad-Boudia M, Nicole A, Thevenin M, Hellier G, Legrain S, Berr C (1996) Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type-place of the extracellular glutathione peroxidase. Free Radic Biol Med 20, 579-587. (Pubitemid 26097275)
64. Banerjee R (2007) Redox Biochemistry. Wiley, New York.
65. Raygani AV, Zahrai M, Doosti M, Javadi E, Rezaei M, Pourmoyabbed T (2005) Association between apolipopro-tein E polymorphism and Alzheimer disease in Tehran, Iran. Neurosci Lett 375, 1-6. (Pubitemid 40139057)
66. Strittmatter WJ, Saunders AM, Schemechel D (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Natl Acad Sci USA 90, 1977-1981. (Pubitemid 23069980)
67. Tilley L, Morgan K, Kalsheker N (1998) Genetic risk in Alzheimer's disease. J Clin Pathol: Mol Pathol 51, 293-304.
68. McNamara MJ, Gomez-Isla T, Imán BT (1998) Apolipopro-tein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease. Arch Neurol 55, 1001-1004. (Pubitemid 28335120)
69. Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT (2000) Apolipoprotein E facilitates neuritic and cerebrovas-cular plaque formation in an Alzheimer's disease model. Ann Neurol 47, 739-747. (Pubitemid 30390194)
70. Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 98, 8838-8843. (Pubitemid 32678114)
71. Allen SJ, MacGowan SH, Tyler S, Wilcock GK, Robertson AG, Holden PH, Smith SK, Dawbarn D (1997) Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci Lett 239, 33-36. (Pubitemid 28055843)
72. Miyata M, Smith JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14, 55-61. (Pubitemid 26301547)
73. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Artherosclerosis 8, 1-21. (Pubitemid 18049171)
74. Ihara Y, Hayabara T, Sasaki K, Kawada R, Nakashima Y, Kuroda S (2000) Relationship between oxidative stress and apoE phenotype in Alzheimer's disease. Acta Neurol Scand 102, 346-349.
75. Fernandes MAS, Proença MT, Nogueira AJA, Grazina MMM, Oliveira LMV, Fernandes AIP, Santiago B, Santana I, Oliveira CR (1999) Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients. Int J Mol Med 4, 179-186.
76. Fernandes MAS, Proença MT, Nogueira AJ, Oliveira LMV, Santiago B, Santana I, Oliveira CR (1999) Apolipoprotein E genotype has no effect on the free intracellular Ca2b concentration of platelets from Alzheimer's disease patients. Int J Mol Med 3, 431-434.
77. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimeŕs disease. Neurobiol Aging 24, 915-919. (Pubitemid 36962976)
78. Aybek H, Ercan F, Aslan D, Sahiner T (2007) Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey. Clin Biochem 40, 172-176. (Pubitemid 46108698)
79. Marcourakis T, Bahia VS, Kawamoto EM, Munhoz CD, Gorjão R, Artes R, Kok F, Caramelli P, Nitrini R, Curi R, Scavone C (2008) Apolipoprotein E genotype is related to nitric oxide production in platelets. Cell Biochem Funct 26, 852-858.
80. Baldeiras I, Santana I, Proença MT, Garrucho MH, Pascoal R, Rodrigues A, Duro D, Oliveira CR (2008) Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. J Alzheimers Dis 15, 117-128.
81. Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, Mecocci P (2009) Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 8, 285-305.